<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">epilepsia</journal-id><journal-title-group><journal-title xml:lang="en">Epilepsy and paroxysmal conditions</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпилепсия и пароксизмальные состояния</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2077-8333</issn><issn pub-type="epub">2311-4088</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">epilepsia-211</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC EVENTS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ МЕРОПРИЯТИЯ</subject></subj-group></article-categories><title-group><article-title></article-title><trans-title-group xml:lang="ru"><trans-title>РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ О ПРИМЕНЕНИИ ТОПАМАКСА В ЛЕЧЕНИИ ЭПИЛЕПСИИ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Статья</surname><given-names>Редакционная</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2011</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2016</year></pub-date><volume>3</volume><issue>2</issue><fpage>6</fpage><lpage>8</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Статья Р., 2016</copyright-statement><copyright-year>2016</copyright-year><copyright-holder xml:lang="ru">Статья Р.</copyright-holder><copyright-holder xml:lang="en">Статья Р.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.epilepsia.su/jour/article/view/211">https://www.epilepsia.su/jour/article/view/211</self-uri><trans-abstract xml:lang="ru"><p>.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kwan P, Sills GJ, Brodie MJ The mechanisms of action of commonly used antiepileptic drugs // Pharmacology &amp; Therapeutics 90 (2001) 21– 34</mixed-citation><mixed-citation xml:lang="en">Kwan P, Sills GJ, Brodie MJ The mechanisms of action of commonly used antiepileptic drugs // Pharmacology &amp; Therapeutics 90 (2001) 21– 34</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Faught E. Topiramate in the treatment of partial and generalized epilepsy Neuropsychiatric Disease and Treatment 2007:3(6) 811–821</mixed-citation><mixed-citation xml:lang="en">Faught E. Topiramate in the treatment of partial and generalized epilepsy Neuropsychiatric Disease and Treatment 2007:3(6) 811–821</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">K.A. Lyseng-Williamson and L.P. Yang, Topiramate: a review of its use in the treatment of epilepsy, Drugs 67 (2007), pp. 2231–2256</mixed-citation><mixed-citation xml:lang="en">K.A. Lyseng-Williamson and L.P. Yang, Topiramate: a review of its use in the treatment of epilepsy, Drugs 67 (2007), pp. 2231–2256</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.</mixed-citation><mixed-citation xml:lang="en">Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacological Research, Vol. 35, No. 4, 1997</mixed-citation><mixed-citation xml:lang="en">Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacological Research, Vol. 35, No. 4, 1997</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003 Mar; 39 (3): Mar; 107 (3): 165-75</mixed-citation><mixed-citation xml:lang="en">Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003 Mar; 39 (3): Mar; 107 (3): 165-75</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1016-26</mixed-citation><mixed-citation xml:lang="en">Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1016-26</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1000-15</mixed-citation><mixed-citation xml:lang="en">Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1000-15</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">К.Ю. Мухин, М.Д. Тысячина, Л.Н. Мухина, А.С. Петрухин Сравнительная эффективность и переносимость топирамата, вальпроатов и карбамазепина в монотерапии эпилепсии у детей и молодых взрослых // Рус журн дет невр. – 2008. – Т.III. – Вып. 2. – С. 3-48.</mixed-citation><mixed-citation xml:lang="en">К.Ю. Мухин, М.Д. Тысячина, Л.Н. Мухина, А.С. Петрухин Сравнительная эффективность и переносимость топирамата, вальпроатов и карбамазепина в монотерапии эпилепсии у детей и молодых взрослых // Рус журн дет невр. – 2008. – Т.III. – Вып. 2. – С. 3-48.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Arroyo S, Dodson WE, Privitera MD, et al. Randomized dose- controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005 Oct; 112 (4): 214-22</mixed-citation><mixed-citation xml:lang="en">Arroyo S, Dodson WE, Privitera MD, et al. Randomized dose- controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005 Oct; 112 (4): 214-22</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Guerrini R, Carpay J, Groselj J, et al. Topiramate monotherapy as broadspectrum antiepileptic drug in a naturalistic clinical setting. Seizure 2005 Sep; 14 (6): 371-80</mixed-citation><mixed-citation xml:lang="en">Guerrini R, Carpay J, Groselj J, et al. Topiramate monotherapy as broadspectrum antiepileptic drug in a naturalistic clinical setting. Seizure 2005 Sep; 14 (6): 371-80</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Glauser TA, Levisohn PM, Ritter F, et al. Topiramate in Lennox- Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000; 41 Suppl. 1: S86-90</mixed-citation><mixed-citation xml:lang="en">Glauser TA, Levisohn PM, Ritter F, et al. Topiramate in Lennox- Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000; 41 Suppl. 1: S86-90</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wheless WJ, Neto W, Wang S; EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy // J Child Neurol. 2004 Feb;19(2):135-41</mixed-citation><mixed-citation xml:lang="en">Wheless WJ, Neto W, Wang S; EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy // J Child Neurol. 2004 Feb;19(2):135-41</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Levisohn PM, Holland KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison // Epilepsy Behav. 2007 Jun;10(4):547-52.</mixed-citation><mixed-citation xml:lang="en">Levisohn PM, Holland KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison // Epilepsy Behav. 2007 Jun;10(4):547-52.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Coppola G. Treatment of partial seizures in childhood: an overview// CNS Drugs. 2004;18(3):133-56</mixed-citation><mixed-citation xml:lang="en">Coppola G. Treatment of partial seizures in childhood: an overview// CNS Drugs. 2004;18(3):133-56</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mikkonen K., Va niopaa K., Pakarinen A.J. et al. Long-term reproducyive endocrine health in yong women with epilepsy during puberty // Neurology. — 2004. — V. 62. — P. 445-50.</mixed-citation><mixed-citation xml:lang="en">Mikkonen K., Va niopaa K., Pakarinen A.J. et al. Long-term reproducyive endocrine health in yong women with epilepsy during puberty // Neurology. — 2004. — V. 62. — P. 445-50.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Morrell M.J., Montouris G.D. Reproductive disturbances in patients with epilepsy // Cleveland Clinic J Med. — 2004. — V. 71</mixed-citation><mixed-citation xml:lang="en">Morrell M.J., Montouris G.D. Reproductive disturbances in patients with epilepsy // Cleveland Clinic J Med. — 2004. — V. 71</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">(Suppl. 2). — P. 19-24</mixed-citation><mixed-citation xml:lang="en">(Suppl. 2). — P. 19-24</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Pack A. M., Gidal B., Vazquez B. Bone disease associated with antiepilaptic drugs // Cleveland clinic journal of medicine. – 2004. – V. 71. – (Suppl 2) – P. 42-49</mixed-citation><mixed-citation xml:lang="en">Pack A. M., Gidal B., Vazquez B. Bone disease associated with antiepilaptic drugs // Cleveland clinic journal of medicine. – 2004. – V. 71. – (Suppl 2) – P. 42-49</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Penovich P.E., Eck K.E., Economou V.V. Recommendation for care of women with epilepsy // Cleveland Clin J Med. — 2004. — V. 71 (Suppl. 2). — P. 49-58.</mixed-citation><mixed-citation xml:lang="en">Penovich P.E., Eck K.E., Economou V.V. Recommendation for care of women with epilepsy // Cleveland Clin J Med. — 2004. — V. 71 (Suppl. 2). — P. 49-58.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Воронкова К.В. и соавт. Рациональная антиэпилептическая фармакотерапия. – М.: Бином пресс, 2008. – 192 с.</mixed-citation><mixed-citation xml:lang="en">Воронкова К.В. и соавт. Рациональная антиэпилептическая фармакотерапия. – М.: Бином пресс, 2008. – 192 с.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Goldensohn E.S., Glaser G.H., Goldberg M.A. Epilepsy //In: Merrits textbook of neurology/ Eds L.P.Rowland. – Lea@Febiger,</mixed-citation><mixed-citation xml:lang="en">Goldensohn E.S., Glaser G.H., Goldberg M.A. Epilepsy //In: Merrits textbook of neurology/ Eds L.P.Rowland. – Lea@Febiger,</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">– 798 p.</mixed-citation><mixed-citation xml:lang="en">– 798 p.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gros elj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A., Schwalen S. Experience with topiramate monotherapy in elderly patients with recent onset epilepsy // Acta Neurol Scand 2005: 112: 144–150.</mixed-citation><mixed-citation xml:lang="en">Gros elj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A., Schwalen S. Experience with topiramate monotherapy in elderly patients with recent onset epilepsy // Acta Neurol Scand 2005: 112: 144–150.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ben-Menachem E. et al. Predictors of weight loss in adults with topiramate treated epilepsy // Obes Res. – 2003. – V. 11. – P. 556-62.</mixed-citation><mixed-citation xml:lang="en">Ben-Menachem E. et al. Predictors of weight loss in adults with topiramate treated epilepsy // Obes Res. – 2003. – V. 11. – P. 556-62.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly.// Neurology. 2004 Nov 23;63(10 Suppl 4):S40-8.</mixed-citation><mixed-citation xml:lang="en">Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly.// Neurology. 2004 Nov 23;63(10 Suppl 4):S40-8.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bourgeois BF. Drug interaction profile of topiramate.// Epilepsia. 1996;37 Suppl 2:S14-S17.26. Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A</mixed-citation><mixed-citation xml:lang="en">Bourgeois BF. Drug interaction profile of topiramate.// Epilepsia. 1996;37 Suppl 2:S14-S17.26. Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.</mixed-citation><mixed-citation xml:lang="en">Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial .monotherapy for epileptic seizures and syndromes // Epilepsia. — 2006. — V. 47. — P. 1094– 120.</mixed-citation><mixed-citation xml:lang="en">Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial .monotherapy for epileptic seizures and syndromes // Epilepsia. — 2006. — V. 47. — P. 1094– 120.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Epilepsy NICE guideline October 2004</mixed-citation><mixed-citation xml:lang="en">Epilepsy NICE guideline October 2004</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">FDA Approved Labeling Text dated 6/29/05; Package Insert – TOPAMAX®, HIGHLIGHTS OF PRESCRIBING INFORMATION, Revised December 2009, http://www.accessdata.fda.gov</mixed-citation><mixed-citation xml:lang="en">FDA Approved Labeling Text dated 6/29/05; Package Insert – TOPAMAX®, HIGHLIGHTS OF PRESCRIBING INFORMATION, Revised December 2009, http://www.accessdata.fda.gov</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">AAN Guideline Summary for clinicians efficacy and tolerability of the new antiepileptic drugs, 1: the new antiepileptic drugs,1: treatment of the new onset epilepsy. NEUROLOGY 2004, 62:1252-60</mixed-citation><mixed-citation xml:lang="en">AAN Guideline Summary for clinicians efficacy and tolerability of the new antiepileptic drugs, 1: the new antiepileptic drugs,1: treatment of the new onset epilepsy. NEUROLOGY 2004, 62:1252-60</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">К.Ю.Мухин, А.С.Петрухин, М.Б.Миронов. Клиническая эффективность и переносимость Топамакса при комбинированной терапии эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(3):28-33.</mixed-citation><mixed-citation xml:lang="en">К.Ю.Мухин, А.С.Петрухин, М.Б.Миронов. Клиническая эффективность и переносимость Топамакса при комбинированной терапии эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(3):28-33.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Глухова Л.Ю., Мухин К.Ю., Петрухин А.С., Миронов М.Б. Топамакс в лечении симптоматической лобной эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(12):51-2.</mixed-citation><mixed-citation xml:lang="en">Глухова Л.Ю., Мухин К.Ю., Петрухин А.С., Миронов М.Б. Топамакс в лечении симптоматической лобной эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(12):51-2.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">К.Ю. Мухин, Л.Ю. Глухова, А.С. Петрухин, М.Б. Миронов, А.М. Соборнова. Топамакс при монотерапии эпилепсии// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2004;104: 8: 35-40</mixed-citation><mixed-citation xml:lang="en">К.Ю. Мухин, Л.Ю. Глухова, А.С. Петрухин, М.Б. Миронов, А.М. Соборнова. Топамакс при монотерапии эпилепсии// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2004;104: 8: 35-40</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">K.Yu.Mukhin, A.S.Petrukin, M.B.Mironov. Topiramate as an add-on therapy in symptomatic partial epilepsies in children// Poster P 108// Psychiatric aspect of the epilepsies. Issues of comorbidity in</mixed-citation><mixed-citation xml:lang="en">K.Yu.Mukhin, A.S.Petrukin, M.B.Mironov. Topiramate as an add-on therapy in symptomatic partial epilepsies in children// Poster P 108// Psychiatric aspect of the epilepsies. Issues of comorbidity in</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">pediatric epilepsy// Bielefeld, Germany, May 29th – June 1st, 2003</mixed-citation><mixed-citation xml:lang="en">pediatric epilepsy// Bielefeld, Germany, May 29th – June 1st, 2003</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Алиханов А.А., Петрухин А.С. Электро-клиническая характеристика больных симптоматической фокальной эпилепсией с феноменом вторичной билатеральной синхронизации на ЭЭГ.// Русский журнал детской неврологии, 2006, том 1 выпуск 1, стр.6-17</mixed-citation><mixed-citation xml:lang="en">Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Алиханов А.А., Петрухин А.С. Электро-клиническая характеристика больных симптоматической фокальной эпилепсией с феноменом вторичной билатеральной синхронизации на ЭЭГ.// Русский журнал детской неврологии, 2006, том 1 выпуск 1, стр.6-17</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Петрухин А.С. Применение Топамакса в монотерапии у детей. Русский журнал детской неврологии, 2006, том 1 выпуск 2, стр.3-9</mixed-citation><mixed-citation xml:lang="en">Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Петрухин А.С. Применение Топамакса в монотерапии у детей. Русский журнал детской неврологии, 2006, том 1 выпуск 2, стр.3-9</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Мухин К.Ю., Петрухин А.С., Миронов М.Б. Клинический случай применения Топамакса в лечении юношеской миоклонической эпилепсии с фотосенситивностью. Вестник эпилептологии. 2006. №1 (05), 17-21.</mixed-citation><mixed-citation xml:lang="en">Мухин К.Ю., Петрухин А.С., Миронов М.Б. Клинический случай применения Топамакса в лечении юношеской миоклонической эпилепсии с фотосенситивностью. Вестник эпилептологии. 2006. №1 (05), 17-21.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
